HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Nephrology
Meta-analysis
Selective aldosterone synthase inhibitors reduce systolic blood pressure by 7.9 mmHg in patients with CKD
Aldosterone Synthase Inhibitors May Lower Blood Pressure in CKD Patients
This meta-analysis of 1148 patients with CKD and uncontrolled hypertension found that selective aldosterone synthase inhibitors (ASIs) reduc…
New research suggests that aldosterone synthase inhibitors could help manage high blood pressure and kidney damage in patients with chronic …
Oct 3, 2026
Diabetes & Endocrinology
Sys. Review
Review of mineralocorticoid receptor antagonists and aldosterone synthase inhibitors for primary aldosteronism
High Blood Pressure Isn't the Only Danger
This narrative review examines the use of mineralocorticoid receptor antagonists and aldosterone synthase inhibitors in patients with primar…
Controlling your blood pressure is not enough to protect your heart if you have this specific type of high blood pressure.
Frontiers
Apr 16, 2026